"Sen. Patty Murray (Wash.) [said] that she was “alarmed” by the appointment of Giroir as interim FDA chief, saying that he has a “track record of letting ideology drive decisions at the expense of women and families.” An aide said the senator was referring to Giroir’s involvement in policy changes that reduce women’s access to health care, in particular reproductive rights."